Top compounds associated with response to MYBL2

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	BRD-K71935468	CTRPv2	pan-cancer	AAC	-0.016	0.7
mRNA	GDC-0449	FIMM	pan-cancer	AAC	0.081	0.7
mRNA	darinaparsin	CTRPv2	pan-cancer	AAC	0.021	0.7
mRNA	ELCPK	CTRPv2	pan-cancer	AAC	0.02	0.7
mRNA	BRD-K27188169:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.021	0.7
mRNA	Methotrexate	GDSC1000	pan-cancer	AAC	0.012	0.7
mRNA	Cyclopamine	GDSC1000	pan-cancer	AAC	0.021	0.7
mRNA	masitinib	GDSC1000	pan-cancer	AAC	-0.012	0.7
mRNA	Bortezomib	gCSI	pan-cancer	AAC	-0.021	0.7
mRNA	Imatinib	GDSC1000	pan-cancer	AAC	-0.021	0.7

Download CSV